Background: Cancers develop in a complex mutational landscape. Interaction of genetically abnormal cancer cells with normal stromal cells can modify the local microenvironment to promote disease progression for some tumor types. Genetic models of tumorigenesis provide the opportunity to explore how combinations of cancer driver mutations confer distinct properties on tumors. Previous Drosophila models of EGFR-driven cancer have focused on epithelial neoplasia. Results: Here, we report a Drosophila genetic model of EGFRdriven tumorigenesis in which the neoplastic transformation depends on interaction between epithelial and mesenchymal cells. We provide evidence that the secreted proteoglycan Perlecan can act as a context-dependent oncogene cooperating with EGFR to promote tumorigenesis. Coexpression of Perlecan in the EGFR-expressing epithelial cells potentiates endogenous Wg/Wnt and Dpp/BMP signals from the epithelial cells to support expansion of a mesenchymal compartment. Wg activity is required in the epithelial compartment, whereas Dpp activity is required in the mesenchymal compartment. This genetically normal mesenchymal compartment is required to support growth and neoplastic transformation of the genetically modified epithelial population. Conclusions: We report a genetic model of tumor formation that depends on crosstalk between a genetically modified epithelial cell population and normal host mesenchymal cells. Tumorigenesis in this model co-opts a regulatory mechanism that is normally involved in controlling growth of the imaginal disc during development.
Introduction
During development, different cell types within an organ communicate through interactions involving direct cell-cell contact, secreted signaling molecules, and extracellular matrix (ECM). The interchange of information guides the organization of the cells into tissues and organs and later contributes to tissue homeostasis. Solid tumors also contain different cell types. However, during tumorigenesis, the communication between these cell types may be disrupted so that tissue homeostasis is destabilized. The tumor becomes a structurally and functionally abnormal organ [1, 2] . ECM is a critical element mediating crosstalk between cell types during normal development, and expression of ECM components is frequently deregulated in some cancers [3] . Understanding how ECM modulates interactions between the tumor cells and their stromal environment will be important for understanding disease progression.
Cancers display another level of complexity: tumors accumulate mutations. Signaling via EGFR promotes tissue growth during normal development, and activating mutations in EGFRs have been recognized as driver mutations in human cancer [4] . Although expression of EGFRs is altered in many epithelial tumors, cooperation with multiple oncogenic lesions is required for disease progression [5] . Cancer genome sequence data have identified multiple genetic abnormalities present in cancer cells [6] . However, the relevance of most of those mutations in cancer remains unclear. Function-based evidence for the involvement of previously unrecognized genes in tumor formation could offer new insights into disease mechanisms.
Carcinomas originating in epithelial tissues are among the most-common human cancers. Drosophila imaginal disc epithelia have been successfully used to study tumor progression and oncogenic cooperation [7] [8] [9] [10] [11] (reviewed in [12] ). The study of cell interactions and cell-ECM interactions in tumorigenesis likewise calls for simple genetic models that can recapitulate these features of the disease in vivo.
Here, we report that misregulation of the ECM component Perlecan cooperates with EGFR in tumor formation in a Drosophila tumor model. Perlecan, the product of the Drosophila gene trol, is a secreted heparan sulfate proteoglycan (HSPG). Perlecans stabilize growth factor-receptor signaling complexes and have roles in diverse developmental processes and in disease [13] [14] [15] [16] . Perlecan upregulation cooperates with EGFR in formation of tumors that are composed of a mix of mutant epithelial cells and wild-type mesenchymal cells, resembling the organization observed in some human tumors [2] . We show that the oncogene-expressing epithelial cells promote cell proliferation and amplification of the endogenous mesenchymal cell population. Reciprocally, the mesenchymal cell population is required to support tumor growth, indicating that bidirectional crosstalk between the genetically modified epithelial cells and their otherwise normal mesenchymal neighbors is required for tumor formation.
Results
Synergistic Interaction between pipsqueak and EGFR EGFR overexpression in imaginal disc epithelial cells leads to benign tissue hyperplasia, accompanied by MAPK pathway upregulation ( [17] ; Figures 1A and 1B ). When combined with other cooperating factors, such as bantam microRNA (miRNA) expression, EGFR overexpression can lead to neoplasia and metastasis [11] . Several other miRNAs were found to cooperate with EGFR to produce tumors, including miR-10 and miR-375. pipsqueak (psq) was predicted to be a target of these two miRNAs. When depleted on its own, psq did not cause an obvious overgrowth phenotype ( Figure 1C ), but depletion of psq in cells overexpressing EGFR led to massive tissue overgrowth ( Figure 1D ; efficacy of psq RNAi is shown in Figure S1 available online). Three independent psq RNAi lines produced comparable effects.
EGFR-expressing discs normally retain a pseudostratified epithelial arrangement, and cells show normal apicobasal polarity [11] . Overproliferation is partially offset by elevated levels of apoptosis. In contrast, discs expressing EGFR with psq RNAi grew as large multilayered masses (for convenience, these will be called EGFR-psq
RNAi
). Optical sections of the EGFR-psq RNAi discs after 4 days of growth revealed a complex morphology, with layers of GFP-expressing cells intermingled with populations of cells that did not express GFP ( Figure 1E ). The GFP-positive cells formed epithelial sheets, with normal apicobasal polarity, revealed by apical accumulation of DECadherin ( Figure 1E ). By 7 days growth, DE-Cadherin uniformly outlined the cells but did not show a polarized apical localization ( Figures 1F and 1G) , suggesting that the epithelial organization of the GFP-positive cells had been lost. Islands of GFP-positive cells were intermingled with groups of cells not expressing GFP.
EGFR-psq
RNAi Discs Undergo Neoplastic Transformation and Metastasize EGFR-psq RNAi larvae did not enter pupariation, and the discs continued to grow, often filling the anterior half of the larva (Figures 2A and 2B ). GFP-positive masses were frequently seen growing at ectopic sites in these animals ( Figure 2B , arrows). We observed invasion of the GFP-positive imaginal disc cells into internal organs, including the gut and malphigian tubules ( Figures 2C and 2D ). Matrix metalloprotease-1 (Mmp1) expression was upregulated compared to control discs (Figures 2E and 2F ). An mmp-1 lacZ reporter showed that mmp1 expression was broadly induced in the epithelial cells (Figure S2A) . Consistent with elevated expression of the secreted Mmp1, basement membranes were degraded in these discs (Figures 2G and 2H ; for further examples, see Figures S2B-S2E). mmp1-lacZ induction reflects activation of the JNK pathway [18] . These observations suggest that the EGFRpsq RNAi tissue had undergone neoplastic transformation and had become metastatic, displaying key characteristic features: epithelial-mesenchymal transition (EMT), accompanied by disruption of the basement membrane as a consequence of upregulation of matrix metalloproteases [18, 19] .
Multiple Tissue Types in EGFR-psq
RNAi Tumors We were intrigued by the observation that these tumorous discs contained a mixture of GFP-positive epithelial cells and Figure S3A ). Adepithelial cells are normally located below the portion of the wing disc epithelium that makes the thoracic body wall (notum). Proximity of the EGFR-psq RNAi -expressing cells to the adepithelial population proved to be important for tumor formation. Use of nubbin-Gal4, which is specific to the wing pouch, produced epithelial hyperplasia but no tumors, whereas two different Gal4 drivers whose expression domains included the notum region produced tumors ( Figure S3B ). The EGFR-psq
RNAi tumors consisted of a mixture of genetically modified GFP-positive epithelial cells and a population of unmodified endogenous mesenchymal cells.
Signaling from the Epithelial Cells to the Mesenchymal Cells
The presence of an extensive mesenchymal cell population in the tumors suggested that their expansion might be driven by signals from the EGFR-psq RNAi -expressing epithelial cells. A brief 20 min 5-ethynyl-2 0 -deoxyuridine (EdU) pulse labeled many epithelial and mesenchymal cells in the tumors, indicating that proliferation of both populations was rapid (Figure 4A ). To get a more-precise view of proliferation in these discs, we made use of an antibody specific to the phosphorylated form of histone H3 (PH3), which selectively labels cells undergoing mitosis [20] . Because M phase is relatively short, fewer dividing cells were captured in each tumorous disc, allowing a more-accurate definition of where division was taking place ( Figure 4B ). Counting PH3-positive cells showed that proliferation of the epithelial and mesenchymal cells was comparable but that most of the dividing mesenchymal cells were adjacent to the epithelial layer ( Figure 4C ). These observations suggest local expansion of the mesenchymal population in the response to cues from the epithelial cells. Dpp and Wg are important drivers of proliferation within the imaginal disc epithelia [21, 22] . An antibody to the phosphorylated form of the Dpp signal transducer MAD showed elevated pMAD label in the mesenchymal cells adjacent to the epithelial layers, indicative of elevated Dpp signaling activity ( Figure 4D) . Notably, the intensity of the pMAD signal decreased with distance from the epithelium, suggesting that the EGFR-psq RNAi tissue served as the source of Dpp. Consistent with this, we observed dpp expression in the epithelial population by using a dpp-lacZ reporter ( Figure 4E ) and by using in situ hybridization to visualize dpp mRNA ( Figure S4A ). To test whether this Dpp activity was required for tumorous growth of the discs, we coexpressed a UAS-RNAi transgene to deplete Dpp in the EGFR-psq RNAi tissue. Preventing Dpp expression in the epithelial cells led to a striking reduction of the growth of the tumorous discs ( Figure 4F ). Similar results were obtained for Wg, which was upregulated in the EGFR-psq RNAi tissue and was required for tumorous overgrowth ( Figure S4B ).
Perlecan Cooperates with EGFR in Tumor Formation
HSPGs serve as cofactors for Wnt and Dpp signaling [16] . We noted that the intensity of pMAD labeling in the epithelial cells themselves was lower than it was in the nearby mesenchymal cells ( Figure 4D ). This suggested that HSPGs might be involved in potentiating growth factor signaling in the mesenchymal cells. Because only the epithelial cells were genetically modified, we focused on secreted HSPG, which might be able to act on the mesenchymal cells. Perlecan is a secreted HSPG that has been linked to FGF, Hedgehog, Wg, Unpaired, and Dpp activity [23] [24] [25] [26] [27] . We observed that depletion of psq in epithelial cells was sufficient to increase the level of perlecan mRNA ( Figure 5A ). This did not require coexpression of EGFR. In control discs, antibody labeling showed Perlecan on the basement membrane toward the outer face of the disc epithelial and adepithelial layers ( Figure 5B ). In the EGFR-psq
RNAi discs, Perlecan accumulated on the mesenchymal cells (Figures 5C and S5A ). 
To test the impact of Perlecan upregulation in this context, we coexpressed a UAS-Perlecan
RNAi transgene in EGFRpsq RNAi epithelial cells. Perlecan depletion prevented the tumorous growth caused by the EGFR-psq RNAi combination ( Figures 5D and 5E ). Similar results were obtained with an independent UAS-Perlecan RNAi line ( Figure S5B ). Remarkably, Perlecan depletion also restored normal apicobasal polarity and tissue organization to the EGFR-psq RNAi epithelial cells (Figure 5F ). This suggested that Perlecan overexpression is required for the neoplastic transformation of the EGFRpsq RNAi tissue. Overexpression of Perlecan with EGFR proved to be sufficient to drive massive overgrowth and neoplastic transformation ( Figures 5G and 5H) . Expression of Perlecan alone, without coexpression of EGFR, had little effect on growth of the disc ( Figure S5C ). The discs coexpressing EGFR and Perlecan resembled EGFR-psqRNAi discs in certain ways: the intermingling of epithelial and mesenchymal populations and the elevated Dpp signaling in the mesenchymal cells adjacent to the epithelia ( Figures  5I and 5J ). These findings suggest that when overexpressed, Perlecan behaves as a context-dependent oncogene capable of cooperating with EGFR to produce tumors. Upregulation of Perlecan may be the key consequence of the cooperation between psq depletion and EGFR expression. 
E) apG4:UAS-EGFR, UAS-psq
RNAi ; 15B03-lexA: lexAop-reaper third instar wing disc. EGFR is shown in green. Cut is shown in red. DNA is shown in blue. Scale bar of (E) represents 100 mm.
The Mesenchymal Population Is Required for Epithelial Tumor Formation
The observation that depleting Perlecan suppressed all features of the tumorous growth of the EGFR-psq RNAi imaginal discs prompted us to ask whether the expansion of the mesenchymal compartment was required for the epithelial overgrowth and loss of epithelial organization. To address this question, we needed a method that would allow us to independently control gene expression in the epithelial and mesenchymal cell populations. We made use of the two-component lexA system [28] to manipulate expression in the mesenchymal cells, while using Gal4 in the epithelial cells. We prepared a lexA operator transgene that expressed the proapoptotic gene reaper and crossed this to the 15B03-lexA driver, which is expressed in the adepithelial cells. As a control for specificity of the 15B03 driver line, we performed lineage tracing, which showed that 15B03-Gal4 was never expressed in wing disc epithelial cells ( Figure 6A ). 15B03-lexAdriven reaper expression reduced the size of the population Cut expressing adepithelial cells (Figures 6B and 6C) . Ablation of the adepithelial cells in this way effectively suppressed the neoplastic transformation phenotype in the EGFR-psq RNAi imaginal discs (Figures 6D and 6E) . Interestingly, in the wildtype discs, ablation of the adepithelial cells led to reduction in the size of the epithelium comprising the notum region ( Figure 6C ).
Dpp Signaling in the Mesenchymal Population Is Required for Epithelial Tumor Formation
Both Wg and Dpp were expressed in the epithelial cell population in EGFR-psq RNAi imaginal discs and were required for tumorigenesis (Figures 4 and S4) . Interestingly, coexpression of Wg and Dpp, together with EGFR in the epithelial cells, proved to be sufficient for tumorigenesis (Figures 7A-7D ): both were 
GFP is shown in green in (A) and (C)-(F). EGFR is shown in green in (B) and (I). Cut is shown in red in (E). DNA is shown in blue in (A)-(D) and (F)-(I).
(J) Schematic representation of the crosstalk between the epithelial and mesenchymal cell populations in tumor formation. Wild-type: EGFR, Wg, and Dpp signaling are required to support proliferation of the disc epithelial cells. Dpp produced by the epithelial cells is also required to support the mesenchymal population. EGFR-psq tumor: increased EGFR activity leads to increased production of Wg and Dpp. Wg signaling is required within the epithelial cells. Dpp is no longer required in the epithelial cells, but elevated signaling enhances growth of the mesenchymal population. Under normal circumstances, this leads to hyperplasia. Depletion of pipsqueak (psq) leads to increased expression of the secreted HSPG, Perlecan (Pcn). Pcn potentiates Dpp activity in the mesenchymal population, presumably by increasing capture of Dpp by the mesenchymal cells. An as-yet-unidentified signal (growth factor), which feeds back to promote proliferation of the epithelial cells, is produced by the mesenchymal cells. This combination of signaling activities leads to neoplasia. required. As in the case of EGFR coexpression with Perlecan, increased expression of Wg and Dpp with EGFR produced tumors consisting of epithelial and mesenchymal cell populations and showing loss of epithelial integrity ( Figure 7E ). These findings suggest that Perlecan acted as an oncogene by sensitizing the tissue to the endogenous Wg and Dpp induced by EGFR overexpression ( Figure S5C) .
Next, we asked whether Wg and Dpp activities were required in the epithelial cells or in the mesenchymal population to elicit tumorous growth. Expression of a TCF dominant-negative transgene [29] was used to block Wg signaling in the epithelial cells. This blocked EGFR-psq RNAi tumor formation ( Figures 7F and 7G) . In contrast, expression of a UAS-Mad RNAi transgene to block Dpp signaling in the epithelial cells did not reduce tumorous growth ( Figure 7H ). Given that pMAD levels were elevated in mesenchymal cells close to the epithelial cells of the EGFR-psq RNAi tumorous discs (Figure 4D) , we sought to address the role of Dpp signaling in the mesenchymal cells. We prepared a lexA operator transgene that expressed the Mad RNAi transgene and expressed this under control of the 15B03-lexA driver. Reducing Dpp signaling in the mesenchymal population proved to be sufficient to reduce tumorous growth ( Figure 7I ). These experiments provide evidence that Wg is required in the epithelial cells, whereas Dpp activity is required in the mesenchymal population.
Discussion
Accumulating evidence indicates that tumor progression results from the interaction between tumor cells and the surrounding normal cells that make up the tumor microenvironment [2, 30, 31] . Here, we have used the Drosophila wing imaginal disc to dissect the crosstalk between tumor cells and surrounding normal cells, in tumors of epithelial origin. In this model, interaction between the two cell populations is required for tumor growth, neoplastic transformation of the epithelium, and metastasis, even though the genetic modifications were introduced into only one of the two cell populations. The signaling relationships between the two cell populations are depicted schematically in Figure 7J .
Carcinomas express growth factors involved in the communication between cancer cells and tumor-associated normal cells [31] [32] [33] [34] . The role of TGF-b and Wnt signaling pathways in tumor initiation is well known [35] [36] [37] , but their role as mediators of the interaction between tumor cells and stromal cells has been less well studied. We observed that EGFR overexpression induced expression of the endogenous Wg and Dpp genes in the epithelial compartment of the tumors. Wg, together with EGFR, is needed in the epithelial cells to drive tumorous growth. The role of the Dpp pathway is different. Our findings indicate that Dpp, produced by the epithelial cells, acts on the mesenchymal stromal cells. Dpp signaling activity was not required in the epithelial cells themselves for tumorous growth. Instead, downregulation of the Dpp pathway in mesenchymal cells blocked tumorous growth of the epithelial population. This suggests that Dpp signaling elicits a feedback response from the mesenchymal population. As a consequence, the resulting tumors are composed of a mix of mutant epithelial cells and genetically normal mesenchymal cells, resembling organization observed in human tumors.
EGFR is upregulated in many carcinomas. EGFR is able to promote tissue overgrowth, but additional mutations are required for malignant transformation and invasion [7, 11, [38] [39] [40] . Our findings have shown that upregulation of Perlecan is sufficient to cooperate with EGFR to produce neoplastic transformation. Perlecan is a secreted HSPG of the ECM that is overexpressed in many human tumor types (reviewed in [14] ). TGF-b ligands have been shown to promote changes in the tumor microenvironment in mammals (reviewed in [34] ). Perlecan has also been reported to stabilize Wg and promote Wg activity in Drosophila [27] . Thus, Perlecan production could potentiate the effects of Dpp and Wg produced by the epithelial cells. These findings raise the possibility that Perlecans might have a fundamental role in mediating interactions between epithelial tumor cells and mesenchymal stromal cells, in addition to their known roles in tumor angiogenesis [14] .
The crosstalk between tumor and microenvironment determines the phenotype of the tumor. Signaling from the tumor microenvironment can suppress the malignant tumor phenotype, yet the tumor microenvironment can also promote malignant transformation [31] . Our finding that ablation of the mesenchymal cell population reverted the tumor phenotype in this model suggests that signals from the mesenchymal cells are required for tumor progression. This same cell population was required to support growth of the epithelial population in a nontumorous normal tissue context. We postulate that signals from the adepithelial mesenchymal cells sustain proliferation of the epithelial cells and likewise that signals from the epithelia drive proliferation of the mesenchymal cells. This normal feedback mechanism can be coopted to drive growth of the two tissues, as, for example, when EGFR and Perlecan were overexpressed. A remarkable, unexpected aspect of these findings is that this feedback loop appears to be sufficient to drive the epithelial tissue beyond hyperplasia, through neoplastic transformation, and into metastasis.
Experimental Procedures
Drosophila Strains 15B03-lexA and 94D09-Gal4 were provided by Gerry Rubin. mmp1-lacZ is described in [18] , and dpp-lacZ (BS3.0) reporter is described in [41] 
, EP-trol (used to overexpress Perlecan; #11007), UAS-tcf DN (described in [29] ), and dpp-lacZ were obtained from the Bloomington Stock Center. vkg-GFP, also known as vkg G454 , is described in [42] . Lineage tracing with the LexA15B03 driver was performed as described in [43] .
Regulated Overgrowth using Gal80 ts
In experiments involving use of the Gal4/Gal80 system to direct tissue overgrowth, embryos were collected from crosses of the indicated genotypes for 24 hr at 18 C and allowed to develop at 18 C for 5 days to maintain the Gal80-dependent repression of Gal4 until the larvae reached early third instar. Larvae were then transferred to 29 C to induce Gal4 activity and grown for 5 days at 29 C before being processed for immunostaining.
Immunostaining Primary antibodies used in these experiments were as follows: Rabbit antiGal4 (Santa Cruz Biotechnology); rabbit anti-b-gal (Cappel); rat anti-DECadherin (DCAD2); mouse anti-Mmp1 (3A6B4/5H7B11/3B8D12 antibodies were mixed in equal amounts); mouse anti-Cut (2B10); mouse anti-Wg (4D4) (Developmental Studies Hybridoma Bank); rabbit anti-pH3 (Cell Signaling Technology); anti-pMAD (provided by Ed Laufer); rat anti-EGFR (provided by P. Rørth); rabbit anti-Perlecan (provided by Stefan Baumgartner); rabbit anti-Twi (provided by Maria Leptin); and rabbit anti-Psq (provided by Celeste Berg). Alexa Fluor 635 phalloidin was used to label F-actin (Life Technologies). The Click-iT EdU Alexa Fluor 594 (Molecular Probes, Invitrogen) was used to detect cells in S phase following the manufacturer's protocol.
Quantitative Real-Time PCR RNA was extracted using Trizol (Invitrogen) and treated with DNase I (Promega), and oligo-dT-based reverse transcription was performed using the superscript III system (Invitrogen). Real-time quantification was performed using SYBR green reagents on an ABI 7500 Fast Real-Time PCR System (Applied Biosystems).
Construction of pLexAop-reaper and pLexAop-Mad
RNAi DNA encoding the reaper gene was PCR amplified from cDNA clone IP02530 (Berkeley Drosophila Genome Project) as a 5 0 -XhoI to 3 0 -XbaI fragment and cloned into pJFRC19 [28] , replacing the myr-GFP reporter. DNA encoding an inverted repeat targeting mad was PCR amplified from genomic DNA, using primers 5 0 -CGCGGATCCCGCCAAGCAGAAGGAG GTGTG-3 0 and 5 0 -CGCTCTAGACAGAAGGCGGGCTCCGAATAG-3 0 (adapted from [44] ), and was subcloned into pJFRC19 at the XbaI site. Microinjection was performed to target the construct to the attP2 landing site.
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